CHAM
Clear Harbor Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.18M | Sell |
15,240
-34
| -0.2% | -$13.8K | 0.46% | 52 |
|
|
2025
Q1 | $7.6M | Buy |
15,274
+1,856
| +14% | +$924K | 0.6% | 42 |
|
|
2024
Q4 | $6.98M | Buy |
13,418
+1,269
| +10% | +$660K | 0.56% | 42 |
|
|
2024
Q3 | $7.52M | Sell |
12,149
-44
| -0.4% | -$27.2K | 0.61% | 39 |
|
|
2024
Q2 | $6.74M | Buy |
12,193
+756
| +7% | +$418K | 0.58% | 39 |
|
|
2024
Q1 | $6.65M | Buy |
11,437
+621
| +6% | +$361K | 0.58% | 37 |
|
|
2023
Q4 | $5.74M | Buy |
10,816
+850
| +9% | +$451K | 0.53% | 36 |
|
|
2023
Q3 | $5.04M | Buy |
9,966
+1,194
| +14% | +$604K | 0.52% | 41 |
|
|
2023
Q2 | $4.58M | Buy |
8,772
+3,955
| +82% | +$2.06M | 0.45% | 53 |
|
|
2023
Q1 | $2.78M | Buy |
+4,817
| New | +$2.78M | 0.29% | 84 |
|
|
2021
Q3 | – | Sell |
-400
| Closed | -$202K | – | 398 |
|
|
2021
Q2 | $202K | Buy |
+400
| New | +$202K | 0.02% | 320 |
|
|
2021
Q1 | – | Sell |
-560
| Closed | -$261K | – | 357 |
|
|
2020
Q4 | $261K | Buy |
560
+5
| +0.9% | +$2.33K | 0.04% | 242 |
|
|
2020
Q3 | $245K | Sell |
555
-53
| -9% | -$23.4K | 0.04% | 225 |
|
|
2020
Q2 | $220K | Buy |
+608
| New | +$220K | 0.04% | 230 |
|
|
2020
Q1 | – | Sell |
-608
| Closed | -$198K | – | 625 |
|
|
2019
Q4 | $198K | Buy |
+608
| New | +$198K | 0.03% | 264 |
|